HomeHealthcare and Life Sciences North America Autoimmune Disease Treatment Market

North America Autoimmune Disease Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Biologics, Small Molecules, Others), By Application (Rheumatoid Arthritis, Lupus, Multiple Sclerosis), Regional Insights and Forecast to 2034

Report Code: SMI2039PUB | Last Updated : 21 July, 2026 | Base Year : 2025 | Historical Data : 2022-2024 | Region : North America | Format : PDF, Excel | Number of Pages : 140 | Author : Jenny Burkett

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: North America Autoimmune Disease Treatment Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on North America Autoimmune Disease Treatment Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. North America Autoimmune Disease Treatment Market , By Type
    1. Introduction
      1. Market Size and Forecast, By Type
    2. Biologics
      1. Market Size and Forecast, By Region
    3. Small Molecules
      1. Market Size and Forecast, By Region
    4. Others
      1. Market Size and Forecast, By Region
  10. North America Autoimmune Disease Treatment Market , By Application
    1. Introduction
      1. Market Size and Forecast, By Application
    2. Rheumatoid Arthritis
      1. Market Size and Forecast, By Region
    3. Lupus
      1. Market Size and Forecast, By Region
    4. Multiple Sclerosis
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. By Type
          1. Biologics
            1. Small Molecules
              1. Others
              2. By Application
                1. Rheumatoid Arthritis
                  1. Lupus
                    1. Multiple Sclerosis
                  2. U.S.
                    1. By Type
                      1. Biologics
                        1. Small Molecules
                          1. Others
                          2. By Application
                            1. Rheumatoid Arthritis
                              1. Lupus
                                1. Multiple Sclerosis
                              2. Canada
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. North America Autoimmune Disease Treatment Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. AbbVie Inc.
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. Johnson & Johnson
                            3. Pfizer Inc.
                            4. Novartis AG
                            5. Roche Holding AG
                            6. Bristol-Myers Squibb
                            7. Eli Lilly and Company
                            8. Amgen Inc.
                            9. GlaxoSmithKline
                            10. Sanofi
                            11. Takeda Pharmaceutical
                            12. Biogen Inc.
                            13. Regeneron Pharmaceuticals
                            14. Vertex Pharmaceuticals
                            15. UCB S.A.